Tirzepatide being a twin GLP-one and GIP agonist, it can be recommended that the GIP element of twin agonism could be responsible for the additional advantage, supplied the probable good thing about GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more effective than dulaglutide in lowering fasting dietary TAG